Bruker Corporation (BRKR) Cash Flow Statement

The gap between net income and operating cash flow is the central issue in this dataset, and it cuts in both directions across recent quarters. In Q2 2026 operating cash flow was negative at -$77.4M against a net loss of -$52.0M, while Q3 reversed sharply, suggesting that working capital timing rather than underlying earnings power is driving much of the quarterly variance. Investors should monitor whether positive operating cash flow in the latest quarter reflects durable collections or a temporary release of receivables that may reverse.

Such large working capital movements relative to a revenue base near $874M suggest that the business is highly sensitive to the timing of system installations and customer acceptances, consistent with the long recognition cycles for high-field NMR systems. The pattern implies that reported operating cash flow may overstate or understate sustainable cash generation depending on where in the cycle the period falls. Analysts should treat any single quarter's working capital contribution with caution until a multi-quarter trend emerges.

Over the full ten-quarter window, free cash flow has alternated sign repeatedly, with the cumulative total remaining weak relative to reported net income magnitude in several periods. The latest positive quarter is encouraging but is not yet sufficient to establish a trend, since capital expenditure remained modest at roughly 2.5% of revenue and the improvement is largely working-capital driven. Investors should monitor whether free cash flow can sustain positive readings across consecutive quarters.

Stable capex of approximately $21M to $37M per quarter appears to be close to maintenance levels relative to depreciation and amortization of roughly $50M to $58M per quarter, which may indicate that the asset base is being sustained or modestly shrinking in real terms. The low ratio does not by itself confirm efficiency, since growth investment in manufacturing capacity or the BEST superconductor segment may be constrained. Investors should weigh whether this restraint reflects discipline or deferred investment.

Given a Debt/Equity ratio of 0.81 and negative return on equity, the continued dividend payments alongside acquisitions warrant scrutiny, since the cash could alternatively reduce leverage. The data do not show share repurchases in recent quarters, which may suggest management is prioritizing balance-sheet and strategic uses over shareholder buybacks. Investors should monitor whether acquired businesses generate returns that justify the deployed capital.